Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin

✍ Scribed by Cristina Zane; Rossana Capezzera; Raffaella Sala; Marina Venturini; Piergiacomo Calzavara-Pinton

• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 193 KB
• Volume: 39
• Category: Article
• ISSN: 0196-8092
• DOI: 10.1002/lsm.20470

✦ Synopsis

Abstract

Background and Objective

Photodynamic therapy (PDT) using aminolevulinic acid (ALA) has been previously investigated in the treatment of photodamaged skin. The aim was to assess efficacy and tolerability of methylaminolevulinate (MAL) as a substitute for ALA in PDT treatment of actinic keratosis (AK) and photoaging.

Study Design/Materials and Methods

Twenty patients with multiple (n = 137) AKs and severe photodamage of the face were treated. Metvix® (Galderma, France) was applied under occlusion for 3 hours before exposure to 37 J/cm^2^ of red light (Aklilite® CL 128, Photocure, Norway). Two treatments were given at monthly intervals.

Results

The clearance rate of AKs was 88.3%, and global score which we use to rate photoaging, mottled hyperpigmentation, fine lines, roughness, and sallowness of the skin showed improvement, but deep wrinkles, teleangiectasia, facial erythema, and sebaceous gland hypertrophy did not change. The treatments were well tolerated. High‐resolution echography showed an increase in skin thickness, pixels count and area, as well as a reduction of the subepidermal low‐echogenic band (SLEB) thickness.

Conclusion

MAL‐PDT is an effective treatment for multiple AKs. In addition, it improves clinical signs of photodamage of the surrounding skin. Lasers Surg. Med. 39:203–209, 2007. © 2007 Wiley‐Liss, Inc.